Earnings Scheduled For October 27, 2021
Companies Reporting Before The Bell
• McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion.
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength.
Where Thermo Fisher Scientific Stands With Analysts
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter:
Citigroup Upgrades Thermo Fisher Scientific to Buy, Raises Price Target to $700
Citigroup analyst Patrick Donnelly upgrades Thermo Fisher Scientific (NYSE:TMO) from Neutral to Buy and raises the price target from $620 to $700.
Thermo Fisher Scientific Reports Has Assumed Operational Responsibility For New Biologics Manufacturing Site In Lengnau, Switzerland
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland as part of its
Clever Culture Systems Selects Thermo Fisher Scientific as Exclusive US APAS Distributor
Australian medical technology company LBT Innovations Limited (ASX: LBT) is pleased to announce the signing of an exclusive Distribution Agreement for the APAS® Independence in the United States (the Agreement) with Remel Inc., a part of Thermo Fisher Scientific, Inc. (Thermo Fisher).
Key Points:
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and…
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests.
Expert Ratings For Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter: